Browsing by Author/Editor/Contributor Brassat, David

Jump to a point in the index:
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)TypeCat.
2018Durable Efficacy and Safety With Alemtuzumab in CARE-MS I Patients Switching From SC IFNB-1a: 5-Year Follow-up (TOPAZ Study)Steingo, Brian; Oreja-Guevara, Celia; Alroughani, Raed; Brassat, David; Boyko, Alexey N.; McCombe, Pamela; VAN WIJMEERSCH, Bart ; Margolin, David H.; Melanson, Maria; Daizadeh, Nadia; Rodriguez, Claudio E.; Vermersch, PatrickJournal ContributionM
2018Alemtuzumab Provides Durable Efficacy and Safety Over 5 Years After Switching From SC IFNB-1a: Follow-up of Patients From CARE-MS II (TOPAZ Study)VAN WIJMEERSCH, Bart ; Boyko, Alexey N.; Broadley, Simon; Brassat, David; Dive, Dominique; Hupperts, Raymond M. M.; Lycke, Jan; Montalban, Xavier; Sharrack, Basil; Wray, Sibyl; Margolin, David H.; Chung, Luke; Daizadeh, Nadia; Chirieac, Madalina; Wiendl, HeinzJournal ContributionM
2018Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience. Report of an expert meetingAlbrecht, Philipp; Bjorna, Ingrid Kristine; Brassat, David; Farrell, Rachel; FEYS, Peter ; Hobart, Jeremy; Hupperts, Raymond; Linnebank, Michael; Magdic, Jozef; Oreja-Guevara, Celia; Pozzilli, Carlo; Salgado, Antonio Vasco; Ziemssen, TjalfJournal ContributionA1
Showing results 1 to 3 of 3